International Conference on Lupus and Autoimmune Disorders (ICLAAD - 27)

This track will explore the latest innovations in molecular diagnostics for lupus and related autoimmune disorders. Emphasis will be placed on the identification and validation of novel biomarkers that enhance diagnostic accuracy.

This session will focus on the bridge between laboratory discoveries and clinical applications in the field of autoimmune diseases. Presentations will highlight successful translational research initiatives that have led to improved patient outcomes.

This track will examine emerging therapeutic strategies and treatment modalities for managing lupus and its complications. Discussions will include both pharmacological and non-pharmacological approaches to patient care.

This session will delve into the underlying immunological mechanisms that drive lupus and other autoimmune conditions. Research findings will be presented that elucidate the role of immune dysregulation in disease pathogenesis.

This track will address innovative clinical research methodologies tailored for rheumatology studies. Emphasis will be placed on the design, implementation, and analysis of clinical trials in lupus and autoimmune disorders.

This session will focus on the importance of patient-centered approaches in the management of lupus and autoimmune diseases. Presentations will highlight strategies for enhancing patient engagement and improving quality of care.